Key statistics
On Friday, AN2 Therapeutics Inc (ANTX:NSQ) closed at 1.09, 9.00% above its 52-week low of 1.00, set on Jan 05, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.10 |
|---|---|
| High | 1.10 |
| Low | 1.06 |
| Bid | 1.11 |
| Offer | 1.14 |
| Previous close | 1.06 |
| Average volume | 65.79k |
|---|---|
| Shares outstanding | 27.40m |
| Free float | 20.44m |
| P/E (TTM) | -- |
| Market cap | 29.05m USD |
| EPS (TTM) | -1.13 USD |
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
More ▼
- AN2 Therapeutics Announces FDA Clearance to Proceed with 90-Patient Investigator-Initiated Trial (IIT) of Epetraborole in Patients with M. abscessus Lung Disease
- AN2 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business and Scientific Highlights
- AN2 Therapeutics Announces Research Collaboration With GSK to Advance Boron-Based LeuRS-Inhibitors Targeting Tuberculosis (TB)
